AMANDA
ROTGER REGÍ
Ikertzailea 2021-(e)ra arte
![Foto de Marta](/img/nophoto.png)
Marta
Aymerich
Marta Aymerich-rekin lankidetzan egindako argitalpenak (1)
2022
-
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 11, pp. 1196-1205